Home / Cars / Cars: BRIEF-Ziopharm Oncology Announces Initiation Of Phase 1 Trial Evaluating Rapid Personalized Manufacturing Car-T Technology In Patients With Relapsed Cd19+ Leukemias And Lymphomas – Reuters

Cars: BRIEF-Ziopharm Oncology Announces Initiation Of Phase 1 Trial Evaluating Rapid Personalized Manufacturing Car-T Technology In Patients With Relapsed Cd19+ Leukemias And Lymphomas – Reuters

Cars:

July 9 (Reuters) – ZIOPHARM Oncology Inc:

* ZIOPHARM ONCOLOGY ANNOUNCES INITIATION OF PHASE 1 TRIAL EVALUATING RAPID PERSONALIZED MANUFACTURING CAR-T TECHNOLOGY IN PATIENTS WITH RELAPSED CD19+ LEUKEMIAS AND LYMPHOMAS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Read More

About admin

Check Also

Cars: Tesla shares drop sharply in broader tech selloff, falling 17% in morning trading

Cars: Tesla shares drop sharply in broader tech selloff, falling 17% in morning trading

Last Thursday and Friday’s public market sell-off has stretched into this week, with the tech-heavy Nasdaq Composite off 2.5% this morning. But while tech shares are down broadly to start the holiday-shortened week — and are taking stick for bringing down even broader indices — some well-known technology, and technology-ish companies are suffering even more.…

Leave a Reply

Your email address will not be published. Required fields are marked *